HomeVRDN • NASDAQ
add
Viridian Therapeutics Inc
Previous close
$23.92
Day range
$23.09 - $24.50
Year range
$10.93 - $24.75
Market cap
1.78B USD
Avg Volume
2.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 72.00K | 0.00% |
Operating expense | 66.47M | 20.32% |
Net income | -64.99M | -18.03% |
Net profit margin | -90.27K | -18.03% |
Earnings per share | -1.02 | 19.69% |
EBITDA | -72.04M | -21.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 571.37M | 70.92% |
Total assets | 585.66M | 66.63% |
Total liabilities | 56.32M | 58.17% |
Total equity | 529.34M | — |
Shares outstanding | 63.89M | — |
Price to book | 4.64 | — |
Return on assets | -29.68% | — |
Return on capital | -31.21% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -64.99M | -18.03% |
Cash from operations | -46.06M | -1.87% |
Cash from investing | 61.98M | 52.23% |
Cash from financing | 108.00K | -96.48% |
Net change in cash | 16.03M | 1,218.35% |
Free cash flow | -22.46M | 23.72% |
About
Founded
2010
Headquarters
Website
Employees
96